We serve Chemical Name:boc-beta-tbu-d-ala-oh CAS:112695-98-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:boc-beta-tbu-d-ala-oh
CAS.NO:112695-98-4
Synonyms:MFCD00798621;(2R)-4,4-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid
Molecular Formula:C12H23NO4
Molecular Weight:245.31500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.048±0.06 g/cm3 (20 ºC 760 Torr)
Index of Refraction:
PSA:75.63000
Exact Mass:245.16300
LogP:2.79140
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like MFCD00798621 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2R)-4,4-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00798621 Use and application,(2R)-4,4-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid technical grade,usp/ep/jp grade.
Related News: Safety concerns about the J&J vaccine paired with flagging U.S. demand for vaccinations in general have slowed rollout of the one-shot vaccine to a crawl. Close to half of the 21 million doses produced for the United States sit unused. boc-beta-tbu-d-ala-oh manufacturer Analysts at Mizuho Americas, who spoke to Lilly’s management this week, said that may well have now changed. “Overall, it sounds like the approval raises new questions for Lilly (as it does for many of us!),” the firm said in a note to clients. boc-beta-tbu-d-ala-oh supplier Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. boc-beta-tbu-d-ala-oh vendor Safety concerns about the J&J vaccine paired with flagging U.S. demand for vaccinations in general have slowed rollout of the one-shot vaccine to a crawl. Close to half of the 21 million doses produced for the United States sit unused. boc-beta-tbu-d-ala-oh factory Safety concerns about the J&J vaccine paired with flagging U.S. demand for vaccinations in general have slowed rollout of the one-shot vaccine to a crawl. Close to half of the 21 million doses produced for the United States sit unused.
